Core Compliance Engine
Continuous Workflows and Outputs
By Framework
By Situation & Trigger
Learn
Compare Grecta vs:
Company
What actually falls due next year, why the guidance still says 2027, and the notified body queue forming now.
AI Regulation for Medical Devices in Europe: the 2027 Position. What applies, what does not, and what the year is actually for.
The high-risk obligations arrive through Annex I, which puts them in 2028. Everything that can stop you selling arrives before then.
31 December 2027 — the MDR transitional period ends for Class III and Class IIb implantable devices, subject to the stated exceptions. A product that cannot stay on the market has no AI Act problem.
28 January 2028 — the deadline for notified bodies already designated under the MDR or IVDR to apply for AI Act designation. Designation is granted by scope, not in general, so the queue forms during 2027.
2 August 2028 — the AI Act’s high-risk obligations reach medical devices, through Annex I. MDCG 2025-6 says 2 August 2027. It is still the operative guidance on the MDR, IVDR and AI Act interplay, and it was written before the Digital Omnibus moved the date.
Written by Yuliia Habriiel LL.B., AIGP, European Compliance Suite. Regulatory and conformity analysis, not legal advice.